Sunscreens that have been available in Europe and other foreign markets for years remain banned from U.S. stores because of a backlog in the federal bureaucracy.
The ingredients that make the sunscreen superior have been awaiting approval — or any sort of decision — from the Food and Drug Administration for at least 12 years. There are currently eight such ingredients stuck in the system.
Without access to the ingredients, consumers may be blocked from buying the sunscreens that provide the most effective protections against harmful rays.
Congress has a plan to break the 12-year backlog: The House Energy and Commerce Committee on Monday is looking at legislation that would expedite the FDA’s approval process for sunscreen ingredients. Should the panel approval the measure, it would put the bill one step closer to passage.
A companion version of the House bill is pending with the Senate’s Health Committee.
The legislation aims to improve on the federal government’s latest attempt to make itself more nimble in keeping up with sunblock technology: a 2002 procedural change from the FDA that the agency hoped would speed up its approval process.
But without a single ingredient being approved since then, advocates say it’s time for another try.
“FDA’s goal was to create a more streamlined process; it just didn’t work out that way,” says a staff member of the Public Access to SunScreens Coalition. “Everyone — melanoma researchers, the community, manufacturers, patients, even the FDA — everyone agrees the current situation is not working. When you combine that with the increasing rates of skin cancer, it’s a serious public-health concern.”
At stake is more than sunburns: Skin cancer is the most common form of cancer in the United States. more than 2 million cases are diagnosed each year, many of which could be prevented by protecting the skin from sun exposure, according to the American Cancer Society.
Congressional advocates hope they can improve the FDA’s existing procedure without upending the entire system.
Under current law, if an ingredient is on the market in another country for five years, it may go through a process to be determined eligible by the FDA. An advisory committee of experts then weighs in on the safety and effectiveness of the product, and the agency makes the final determination as to whether it is approved.
The Sunscreen Innovation Act makes two primary changes to this process. First, it would institute an eight-month deadline for the FDA to make a decision, replacing a current review process that lacks a mandatory end date. Second, the bill would no longer require the FDA to issue a regulation every time it wants to approve an ingredient.
The FDA declined to comment on the bill, but a spokesperson said the agency has “prioritized reviewing the safety and effectiveness of additional sunscreen ingredients as quickly as possible given the agency’s resources.”
This frustration has boiled over to Capitol Hill, with matching House and Senate bills to address the problem. The House version being considered Monday was introduced by Republican Ed Whitfield and Democrat John Dingell. The Senate version came from Democrat Jack Reed and Republican Johnny Isakson.
With backing from both parties, advocates are cautiously optimistic about the bills becoming law, but they recognize that bipartisan support is no guarantee of passage — particularly in the current gridlocked environment.
“Trying to predict what Congress is going to do is kind of like having a perfect March Madness bracket,” the sunscreens coalition staff member said. “But I will say there has been tremendous bipartisan, bicameral support.”
What We're Following See More »
Howard Dean, the former Vermont governor and Democratic National Committee chair, announced he's pulling out of the running to regain the chairman's post. Dean "announced in a pre-recorded video to a conference of state Democratic chairs that he would step aside to allow for a new face to lead the party as it seeks to rebuild."
"Once again, businessman and philanthropist David M. Rubenstein has come through for the National Park Service. This time, he's pledged funding needed to modernize the Washington Monument's elevator-- but the monument will remain closed until 2019 while repairs and improvements are underway. Rubenstein's donation of between $2-3 million, announced Friday, will correct those ongoing elevator issues, which have shuttered the monument since August 17."
The National Defense Authorization Act passed the House this morning by a 375-34 vote. The bill, which heads to the Senate next week for final consideration, would fund the military to the tune of $618.7 billion, "about $3.2 billion more than the president requested for fiscal 2017. ... The White House has issued a veto threat on both the House and Senate-passed versions of the bill, but has not yet said if it will sign the compromise bill released by the conference committee this week."
"Republicans have elected Rep. Greg Walden (R-OR) the next chairman of the powerful House Energy and Commerce Committee. Walden defeated Reps. John Shimkus (R-IL) and Joe Barton (R-TX), the former committee chairman, in the race for the gavel" to succeed Michgan's Fred Upton.
"Democratic and Republican members of the Senate Judiciary Committee are working on legislation that would limit deportations" under President-elect Donald Trump. Leading the effort are Judiciary Committee members Dick Durbin (D-IL) and Lindsey Graham (R-SC). Sen. Jeff Flake (R-AZ) is also expected to sign on.